iSpecimen
ISPC
11 hedge funds and large institutions have $103K invested in iSpecimen in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
49% more capital invested
Capital invested by funds: $69.1K → $103K (+$34K)
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
10% more funds holding
Funds holding: 10 → 11 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$13.7K |
| 2 |
VF
Virtu Financial
New York
|
+$12.7K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.67K |
| 4 |
Jane Street
New York
|
+$6K |
| 5 |
SG
StoneX Group
New York
|
+$4.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$12.2K |
| 2 |
Millennium Management
New York
|
-$10.2K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.53K |
| 4 |
Renaissance Technologies
New York
|
-$2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$739 |
ISPC Hedge Fund Activity: Q2 2024 in Review
11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2024, worth a combined $103K — up 49% from $69.1K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ISPC positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $13.7K. The largest seller was Vanguard Group, cutting an estimated $12.2K.
- 11 institutional investors held iSpecimen (ISPC) as of Q2 2024, up from 10 in Q1 2024.
- Funds reported $103K of iSpecimen stock for Q2 2024, up 49% quarter-over-quarter.
- 5 funds opened new iSpecimen positions in Q2 2024 and 4 closed out, a net change of +1 holder.
- The largest iSpecimen buyer in Q2 2024 was HRT Financial, an estimated $13.7K added.
- The largest iSpecimen seller in Q2 2024 was Vanguard Group, an estimated $12.2K sold.
Based on aggregated 13F filings for Q2 2024.